According to the United States Department of Agriculture (USDA), in the year 2016, the cattle population was around 92 million. Amongst them, a considerable number of cattle was prone to clostridial diseases. Fortune Business Insights, in an upcoming report, titled, “Veterinary Clostridium Vaccine“ Market, Size, Share and Global Trend By Animal (Ovine, Bovine, Equine, Porcine, Poultry, Others), By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Research Institutes, Others), and Geography Forecast till 2026,” states that increasing demand for meat and animal-based products is projected to boost the global veterinary clostridium vaccine market growth in the forthcoming years.
The report offers present and future outlook of the global veterinary clostridium vaccine market in the emerging as well as developed regions. It further provides segment-wise information for better understanding of each segment and their dominant sub-segments. All segments provided in the report are represented at the country level. The report also covers in-depth analysis of various aspects, namely, growth drivers, key developments, competitive landscape, and obstacles.
Request a Sample Copy of the Research Report:
Increasing Demand for Porcine-based Products to Propel the Porcine Sub-segment
In terms of animal, the global veterinary clostridium vaccine market is categorized into poultry, porcine, ovine, equine, bovine, and others. Amongst these, the porcine sub-segment is projected to hold notable global market share. It is likely to occur due to a rise in the demand for porcine-based products as well as the increasing incidence of zoonotic diseases.
Leading Players operating in the Veterinary Clostridium Vaccine Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- MSD Animal Health
- Bimeda, Inc.
- Bayer AG
- Zoetis Services LLC
- Bimeda, Inc.
- Boehringer Ingelheim International GmbH
- Other market players
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
For more information in the analysis of this report, visit:
The report covers:
- Global Veterinary Clostridium Vaccine Market trends, with detailed analysis on consumer trends & manufacturer trends.
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
- Key areas of investments identifying market opportunities and challenges in forecast timeframe.
- Competitive analysis of the industry players along with the overview on strategic management.
- Comprehensive company profiles of the major industry players.
Increasing Awareness Programs Regarding Animal Welfare to Favor Growth in Asia Pacific
Geographically, the global veterinary clostridium vaccine market is divided into Asia Pacific, the Middle East and Africa, North America, Europe, and Latin America. Out of these regions, North America is leading the global veterinary clostridium vaccine market owing to the increasing prevalence of clostridial diseases in the region. Moreover, a high rate of fatality of the disease, increasing number of clinics and hospitals, and rising rates of livestock are expected to contribute to the market growth. Combined with this, growing number of veterinarians and increasing consumption of animal-based products, such as meat will propel the market in this region. Asia Pacific, on the other hand, is considered to be one of the fastest-growing markets due to a rise in the awareness programs regarding animal welfare and increasing government initiatives. Furthermore, large pool of livestock and rising incidence of clostridial diseases will impact the veterinary clostridium vaccine market in this region positively.
Merc Collaborates with Rapid Genomics to Gain Exclusive Rights to its Viral Flex-Seq
Merck Animal Health, a leading manufacturer of veterinary medicines, headquartered in the U.S., partnered up with Rapid Genomics, a DNA genotyping and genetic data analysis company in February 2019. The agreement would enable Rapid Genomics to grant Merck rights to its vaccination verification tool called Viral Flex-Seq. The tool would be used in combination with Merck Animal Health’s Innovax vaccines.
It would also include Innovax-ND-IBD, an innovative vaccine that protects against three infectious poultry diseases, namely, Marek’s Disease (MD), Infectious Bursal Disease (IBD), and Newcastle Disease (ND) in a single dose. Viral Flex-Seq includes the next-generation sequencing technology to detect copies of Innovax vaccines and separate them from the field viruses. It also provides highly-accurate and sensitive result to confirm the presence of replication in birds.
Segmentation of the Global Veterinary Clostridium Vaccine Market:
By Distribution Channel
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- Online Pharmacies
- Veterinary Research Institutes
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/veterinary-clostridium-vaccine-market-100670
- Extensive product offerings
- Customer research services
- Robust research methodology
- Comprehensive reports
- Latest technological developments
- Value chain analysis
- Potential Veterinary Clostridium Vaccine Market opportunities
- Growth dynamics
- Quality assurance
- Post-sales support
- Regular report updates
Reasons to Purchase this Report:
- Comprehensive analysis of the Veterinary Clostridium Vaccine Market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Related Reports :https://hindaily.com/